Google Mines Healthcare Data For Project ‘Nightingale’
Nobody can deny the fact that the healthcare industry is booming nowadays and has become a multi-billion industry. Due to this, it has been becoming the focus of many giants … Continue Reading Google Mines Healthcare Data For Project ‘Nightingale’
New Ebook on Amazon, Learn How to Break Into the Biotech Industry
Ever wonder how to break into the biotech industry? We are happy to give out a free booklet that details how to break into an industry that is making an … Continue Reading New Ebook on Amazon, Learn How to Break Into the Biotech Industry
Conversations with a CEO: Biotech Brothers Interviews Dr. Alex Zhavoronkov
As someone who writes about pharma and the biotech industry, I get invited to join the sidelines in hearing the stories of innovators in our field. I truly enjoy the … Continue Reading Conversations with a CEO: Biotech Brothers Interviews Dr. Alex Zhavoronkov
High Drug Prices the New Standard
Drug prices has continued to climb to an absurd high price. It is imperative that information about these drugs be made public so that we broaden the awareness about them. … Continue Reading High Drug Prices the New Standard
The Best Paying Jobs in STEM
Pursuing a science job can be amazing since it helps you establish a career and pursue amazing things in life. But at the same time this also comes with its … Continue Reading The Best Paying Jobs in STEM
What is Medicinal Chemistry?
Medicinal chemistry is one of the fields in very high demand at this particular time. It’s a discipline in between pharmacology and chemistry. The focus is on drug discovery and … Continue Reading What is Medicinal Chemistry?
Astellas Pharma Acquires CAR T Startup Xyphos for a Staggering $665 Million
Astellas Pharma will purchase Xyphos Biosciences for a staggering $665 million. A lot of money for CAR T technology that will shape the future for patients fighting cancer. You may … Continue Reading Astellas Pharma Acquires CAR T Startup Xyphos for a Staggering $665 Million
Forma Therapeutics Raises $100 Million in Series D Financing
FORMA Therapeutics, a biopharmaceutical company headquartered in Massachusetts, just sent out a press release announcing that the company raised $100 Million (Yes, a hundred million :O). A monstrous round in … Continue Reading Forma Therapeutics Raises $100 Million in Series D Financing
A Herpes Virus May Be the Cause of Multiple Sclerosis
Can a Herpes Variant be the clue to treating Multiple Sclerosis? With more than 8,700 MS patients and 7200 without MS used as a control group, researchers from Karolinska Institute … Continue Reading A Herpes Virus May Be the Cause of Multiple Sclerosis
CEO Leaves on La Jolla Pharmaceutical’s Interim Data
An American biopharmaceutical company, La Jolla Pharmaceuticals (NASDAQ: LJPC), dedicated to the development of innovative novel therapies for patients suffering from severe diseases, announced that its CEO has departed from … Continue Reading CEO Leaves on La Jolla Pharmaceutical’s Interim Data
Novartis Acquires The Medicines Company for $9.7 Billion
A Global Switzerland Pharmaceutical, Novartis, has agreed to acquire Medicines Company (NASDAQ: MDCO) for a staggering $9.7 Billion. The Medicines Company, a biopharmaceutical company dedicated to the drug development of … Continue Reading Novartis Acquires The Medicines Company for $9.7 Billion
FDA Approves Beigene’s Brukinsa for Mantle Cell Lymphoma
The United States Food and Drug Administration (FDA) has granted approval to Brukinsa (Zanubrutinib). A blood cancer drug from Chinese company, BeiGene, giving access to Americans to a Chinese cancer … Continue Reading FDA Approves Beigene’s Brukinsa for Mantle Cell Lymphoma
AnaptysBio’s Eczema Drug Fails to Meet Phase II Endpoints
AnaptysBio, Inc. is a clinical-stage biotechnology company that is developing its first in class antibody products that are focused on the unmet medical needs in inflammation. It announced the top-line … Continue Reading AnaptysBio’s Eczema Drug Fails to Meet Phase II Endpoints
Celgene’s Car-T Data Beats its Competitors
Have you heard of CAR T? If you’re new to biotechnology, you may be wondering what I’m talking about. Don’t worry, after reading. You’ll be an expert about this technology, … Continue Reading Celgene’s Car-T Data Beats its Competitors
Harvard Professor uses Gene Therapy to Fight Aging
A renowned Professor of Genetics at Harvard Medical School and director of PersonalGenomes.org, George Church, started a small biotech company in the hope of understanding age-related diseases. Rejuvenate Bio is … Continue Reading Harvard Professor uses Gene Therapy to Fight Aging
An Enzyme May be the Key to Stopping Parkinson’s
Scientists from the University of Dundee and the University of Stanford have made an important discovery in Parkinson’s. These researchers discovered an enzyme that acts as the “brakes” to the … Continue Reading An Enzyme May be the Key to Stopping Parkinson’s
Can you Function on Four Hours of Sleep? A Mutation in NSPR1 Can Explain this Phenomenon
Have you heard your colleague or coworker mention that they work on 4 hours of sleep every day? Yet, you wonder why they don’t mirror a zombie from a nonfiction … Continue Reading Can you Function on Four Hours of Sleep? A Mutation in NSPR1 Can Explain this Phenomenon
